Cabozantinib real-world effectiveness in the first-through fourth-line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Gan CL, Dudani S, Wells JC, Donskov F, Pal SK, Dizman N, Rathi N, Beuselinck B, Yan F, Lalani AA, Hansen A, Szabados B, de Velasco G, Tran B, Lee JL, Vaishampayan UN, Bjarnason GA, Subasri M, Choueiri TK, Heng DYC.
Gan CL, et al. Among authors: pal sk.
Cancer Med. 2021 Feb;10(4):1212-1221. doi: 10.1002/cam4.3717. Epub 2021 Jan 18.
Cancer Med. 2021.
PMID: 33463028
Free PMC article.